Purchases and Sales Made in Q1 2024 in Fusion Pharmaceuticals Inc. (FUSN)
This table provides information about the institutional ownership of Fusion Pharmaceuticals Inc. (FUSN) during Q1 2024. The information is specifically focused on institutions that hold shares of Fusion Pharmaceuticals Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 14, 2024
Q1 2024
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-75K- 0.69% |
$593K - $1.6M
|
10.8M
$0
|
|
|
May 13, 2024
Q1 2024
|
Ubs Group Ag
|
SELL
|
- |
-143K- 64.32% |
$1.13M - $3.06M
|
79.6K
$0
|
|
|
May 15, 2024
Q1 2024
|
Fred Alger Management, LLC
New York, NY |
SELL
|
- |
-145K- 46.34% |
$1.14M - $3.08M
|
167K
$0
|
|
|
May 09, 2024
Q1 2024
|
Blair William & CO
Chicago, IL |
SELL
|
- |
-215K- 21.6% |
$1.7M - $4.58M
|
779K
$0
|
|
|
May 15, 2024
Q1 2024
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
SELL
|
- |
-637K- 58.64% |
$5.03M - $13.6M
|
449K
$0
|
|
|
May 14, 2024
Q1 2024
|
Pivotal Bio Venture Partners Investment Advisor LLC
San Francisco, CA |
SELL
|
- |
-998K- 63.91% |
$7.88M - $21.3M
|
563K
$0
|